Request Demo
Last update 17 Oct 2026
SY-12321
Last update 17 Oct 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms SY 12321, SY12321 |
Target |
Action inhibitors |
Mechanism ALK inhibitors(Anaplastic lymphoma kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with SY-12321NCT07810933
An Open-label, Multicenter Phase Ⅰ/Ⅱ Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SY-12321 in Patients With ALK-positive Advanced Malignancies
100 Clinical Results associated with SY-12321
Login to view more data
100 Translational Medicine associated with SY-12321
Login to view more data
100 Patents (Medical) associated with SY-12321
Login to view more data
100 Deals associated with SY-12321
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| ALK Positive Solid Tumors | Phase 2 | China | 12 Aug 2026 | |
| Anaplastic Large-Cell Lymphoma | Phase 1 | China | 12 Aug 2026 | |
| Breast Cancer | Phase 1 | China | 12 Aug 2026 | |
| Colorectal Cancer | Phase 1 | China | 12 Aug 2026 | |
| Non-Small Cell Lung Cancer | Phase 1 | China | 12 Aug 2026 | |
| Pancreatic Cancer | Phase 1 | China | 12 Aug 2026 | |
| ALK Positive Breast Cancer | IND Approval | China | 15 Jul 2026 | |
| ALK positive Colorectal Cancer | IND Approval | China | 15 Jul 2026 | |
| ALK positive Non-Small Cell Lung Cancer | IND Approval | China | 15 Jul 2026 | |
| ALK positive Pancreatic Cancer | IND Approval | China | 15 Jul 2026 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free